Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section listing participating sites by state (Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah) and included a Revision: v3.3.3 tag. Removed the previous HHS Vulnerability Disclosure entry and older state location entries (v3.3.2).
    Difference
    1%
    Check dated 2025-12-19T21:36:54.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    New revision tag v3.3.2 added with recent dates (e.g., 2025-11-21 and 2025-11-24), replacing the previous revision v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-28T13:07:24.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Minor revision update from v3.2.0 to v3.3.1 with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-21T13:12:11.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The funding-status notice at the top of the ClinicalTrials.gov page has been removed; no trial details, eligibility criteria, or outcomes appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-14T07:57:13.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; core study details and contacts remain the same.
    Difference
    0.2%
    Check dated 2025-10-31T01:40:28.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T12:52:07.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.